HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity
Year: 2022
Type: review
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Funders: European Commission, National Research Foundation, South African Medical Research Council, National Institutes of Health, National Health and Medical Research Council, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Arthritis and Musculoskeletal and Skin Diseases, European and Developing Countries Clinical Trials Partnership
Awards: G1456341435, G1980372524, G1991070941, G2987951818, Improving Prediction of Drug Action, G4046645705, IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study), Stevens-Johnson syndrome/toxic epidermal necrolysis 2021: Collaboration, Innovation and Community, Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Investigating a novel cell population in delayed-onset drug hypersensitivity reactions, IMmune-mediated Adverse drug Reactions In African TB HIV endemic settings, G7206176050, G8117232887, Investigating mechanisms of epidermal cell death in Toxic Epidermal Necrolysis, Immune Tolerance Network, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), HIV-associated Tuberculosis Training Program (HATTP), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
OpenAlex ID: W4312083692